347 related articles for article (PubMed ID: 16019168)
1. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
Frankenfeld CL; McTiernan A; Thomas WK; LaCroix K; McVarish L; Holt VL; Schwartz SM; Lampe JW
Maturitas; 2006 Feb; 53(3):315-24. PubMed ID: 16019168
[TBL] [Abstract][Full Text] [Related]
2. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.
Frankenfeld CL; McTiernan A; Tworoger SS; Atkinson C; Thomas WK; Stanczyk FZ; Marcovina SM; Weigle DS; Weiss NS; Holt VL; Schwartz SM; Lampe JW
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):399-408. PubMed ID: 15145450
[TBL] [Abstract][Full Text] [Related]
3. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
[TBL] [Abstract][Full Text] [Related]
4. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
[TBL] [Abstract][Full Text] [Related]
5. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women.
Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E
J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657
[TBL] [Abstract][Full Text] [Related]
6. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
Törmälä RM; Appt S; Clarkson TB; Tikkanen MJ; Ylikorkala O; Mikkola TS
Climacteric; 2007 Dec; 10(6):471-9. PubMed ID: 18049940
[TBL] [Abstract][Full Text] [Related]
7. Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.
Guo K; Zhang B; Chen C; Uchiyama S; Ueno T; Chen Y; Su Y
Br J Nutr; 2010 Jul; 104(1):118-24. PubMed ID: 20205965
[TBL] [Abstract][Full Text] [Related]
8. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
Frankenfeld CL; Atkinson C; Thomas WK; Gonzalez A; Jokela T; Wähälä K; Schwartz SM; Li SS; Lampe JW
Br J Nutr; 2005 Dec; 94(6):873-6. PubMed ID: 16351761
[TBL] [Abstract][Full Text] [Related]
9. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.
Rowland IR; Wiseman H; Sanders TA; Adlercreutz H; Bowey EA
Nutr Cancer; 2000; 36(1):27-32. PubMed ID: 10798213
[TBL] [Abstract][Full Text] [Related]
10. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability.
Törmälä R; Appt S; Clarkson TB; Mueck AO; Seeger H; Mikkola TS; Ylikorkala O
Climacteric; 2008 Oct; 11(5):409-15. PubMed ID: 18781486
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
Liu ZM; Ho SC; Chen YM; Liu J; Woo J
PLoS One; 2014; 9(2):e87861. PubMed ID: 24533060
[TBL] [Abstract][Full Text] [Related]
12. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women.
Weickert MO; Reimann M; Otto B; Hall WL; Vafeiadou K; Hallund J; Ferrari M; Talbot D; Branca F; Bügel S; Williams CM; Zunft HJ; Koebnick C
J Negat Results Biomed; 2006 Aug; 5():11. PubMed ID: 16907966
[TBL] [Abstract][Full Text] [Related]
14. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
[TBL] [Abstract][Full Text] [Related]
15. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
[TBL] [Abstract][Full Text] [Related]
16. Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children.
Hoey L; Rowland IR; Lloyd AS; Clarke DB; Wiseman H
Br J Nutr; 2004 Apr; 91(4):607-16. PubMed ID: 15035688
[TBL] [Abstract][Full Text] [Related]
17. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women.
Védrine N; Mathey J; Morand C; Brandolini M; Davicco MJ; Guy L; Rémésy C; Coxam V; Manach C
Eur J Clin Nutr; 2006 Sep; 60(9):1039-45. PubMed ID: 16482068
[TBL] [Abstract][Full Text] [Related]
18. Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM; Slavin JL; Lampe JW
J Am Diet Assoc; 1995 May; 95(5):545-51. PubMed ID: 7722188
[TBL] [Abstract][Full Text] [Related]
19. Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.
Atkinson C; Newton KM; Yong M; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
Metabolism; 2012 Dec; 61(12):1678-82. PubMed ID: 22819530
[TBL] [Abstract][Full Text] [Related]
20. Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake.
Lampe JW; Gustafson DR; Hutchins AM; Martini MC; Li S; Wähälä K; Grandits GA; Potter JD; Slavin JL
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):699-707. PubMed ID: 10744130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
